Article
A prospective evaluation of the analytical performance of GENECUBE<sup>®</sup> HQ SARS-CoV-2 and GENECUBE<sup>®</sup> FLU A/B
2021-02-25
Abstract excerpt
<h4>Background</h4> Molecular tests are the mainstay for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, their accessibility can be limited by the long examination time and inability to evaluate multiple samples at once. This study evaluated the analytical performance of the newly developed rapid molecular assays GENECUBE ® HQ SARS-CoV-2 and the GENECUBE ® FLU A/B. <h4>Method</h4>...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5563921-6c0a-512d-b90e-e9b336dd6dae
- DOI
- 10.1101/2021.02.24.21252337
